Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Argus Health
Fuji
Chubb
Cerilliant
Cipla
Boehringer Ingelheim
AstraZeneca
Daiichi Sankyo

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR GATTEX KIT

« Back to Dashboard

Clinical Trials for Gattex Kit

Trial ID Title Status Sponsor Phase Summary
NCT00072839 Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Completed Shire Phase 2 The purpose of the study is to determine whether an investigational compound, ALX-0600, is safe and effective in treating Crohn's Disease.
NCT00081458 Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Completed Shire Phase 3 The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of teduglutide compared with placebo in subjects with parenteral nutrition (PN)-dependent short bowel syndrome (SBS).
NCT00172185 Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458) Completed Shire Phase 3 The purpose of this clinical study is to evaluate the long-term safety and efficacy of daily administration of teduglutide.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Gattex Kit

Condition Name

Condition Name for Gattex Kit
Intervention Trials
Short Bowel Syndrome 6
Postoperative Fistula 1
Pharmacokinetics and Safety of Elevated Doses 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Gattex Kit
Intervention Trials
Syndrome 6
Short Bowel Syndrome 6
Crohn Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Gattex Kit

Trials by Country

Trials by Country for Gattex Kit
Location Trials
United States 55
Canada 13
Germany 6
United Kingdom 6
France 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Gattex Kit
Location Trials
Pennsylvania 6
New York 6
Ohio 5
Georgia 5
District of Columbia 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Gattex Kit

Clinical Trial Phase

Clinical Trial Phase for Gattex Kit
Clinical Trial Phase Trials
Phase 4 1
Phase 3 5
Phase 2 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Gattex Kit
Clinical Trial Phase Trials
Completed 8
Not yet recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Gattex Kit

Sponsor Name

Sponsor Name for Gattex Kit
Sponsor Trials
Shire 7
Massachusetts General Hospital 2
Nycomed Germany GmbH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Gattex Kit
Sponsor Trials
Industry 9
Other 4
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Federal Trade Commission
Express Scripts
US Army
Johnson and Johnson
Julphar
Cantor Fitzgerald
Covington
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.